Detalhe da pesquisa
1.
Intermediate-effect size p.Arg637Gln in FHOD3 increases risk of HCM and is associated with an aggressive phenotype in homozygous carriers.
J Med Genet
; 61(5): 423-427, 2024 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38160043
2.
Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy.
Eur Heart J
; 42(32): 3063-3073, 2021 08 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34263907
3.
Endomyocardial biopsy-confirmed myocarditis and inflammatory cardiomyopathy: clinical profile and prognosis.
Rev Esp Cardiol (Engl Ed)
; 2022 May 03.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-35523665
4.
Prognosis of Transthyretin Cardiac Amyloidosis Without Heart Failure Symptoms.
JACC CardioOncol
; 4(4): 442-454, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36444226
5.
Combination of late gadolinium enhancement and genotype improves prediction of prognosis in non-ischaemic dilated cardiomyopathy.
Eur J Heart Fail
; 24(7): 1183-1196, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35485241
6.
Clinical Risk Score to Predict Pathogenic Genotypes in Patients With Dilated Cardiomyopathy.
J Am Coll Cardiol
; 80(12): 1115-1126, 2022 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36109106
7.
Association of Genetic Variants With Outcomes in Patients With Nonischemic Dilated Cardiomyopathy.
J Am Coll Cardiol
; 78(17): 1682-1699, 2021 10 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34674813